LON:BTEC Holdings Information

LON:BTEC is an equity ETF with a total of 258 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.01%, Amgen at 7.83%, Gilead Sciences at 7.79%, Regeneron Pharmaceuticals at 5.38%, and Moderna at 4.15%.

Total Holdings

258

Top 10 Percentage

44.60%

Asset Class

Equity

ETF Category

Health Care

Assets

842.01M

PE Ratio

25.80

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	8.01%	186,996
2	AMGN	Amgen Inc.	7.83%	248,489
3	GILD	Gilead Sciences, Inc.	7.79%	622,543
4	REGN	Regeneron Pharmaceuticals, Inc.	5.38%	82,224
5	MRNA	Moderna, Inc.	4.15%	316,666
6	RVMD	Revolution Medicines, Inc.	2.77%	169,670
7	ILMN	Illumina, Inc.	2.46%	120,777
8	ALNY	Alnylam Pharmaceuticals, Inc.	2.17%	106,566
9	BIIB	Biogen Inc.	2.14%	117,867
10	ROIV	Roivant Sciences Ltd.	1.91%	574,602
11	ARGX	argenx SE	1.82%	22,036
12	INSM	Insmed Incorporated	1.78%	173,114
13	RPRX	Royalty Pharma plc	1.73%	353,996
14	INCY	Incyte Corporation	1.69%	159,600
15	GH	Guardant Health, Inc.	1.60%	105,609
16	UTHR	United Therapeutics Corporation	1.40%	33,934
17	VTRS	Viatris Inc.	1.32%	931,103
18	MEDP	Medpace Holdings, Inc.	1.16%	22,743
19	JAZZ	Jazz Pharmaceuticals plc	1.01%	49,972
20	NBIX	Neurocrine Biosciences, Inc.	1.01%	80,079
21	EXEL	Exelixis, Inc.	0.97%	200,534
22	ASND	Ascendis Pharma A/S	0.97%	49,028
23	TEM	Tempus AI, Inc.	0.93%	139,581
24	SMMT	Summit Therapeutics Inc.	0.91%	621,639
25	BBIO	BridgeBio Pharma, Inc.	0.87%	156,057

Showing 25 of 258 holdings

Subscribe to see the full list

Activate Now

As of Sep 17, 2026